The processes involved in malignant gliomas damage were quantitatively evaluated by microscopy. The near-infrared fluorescent dye IR700, when it is conjugated to an anti-CD133 antibody (IR700-CD133), specifically targets malignant gliomas (U87MG) and stem cells (BT142) The endocytosed IR700 dye was co-localized in acidic organelles such as endosomes and lysosomes. Moreover, the pH in U87MG cells, as monitored by a pH indicator, was decreased and then gradually increased by the illumination of IR700, while the pH in BT142 cells increased monotonically. In these experiments, the processes of cell damage were quantitatively evaluated according to the motility of vesicles and changes in pH.
Introduction
Malignant gliomas show high invasiveness and spread rapidly via metastasis.
Radiotherapy and chemotherapy have been used to eliminate tumor cells because surgical removal of gliomas is often difficult [1] [2] [3] [4] . However, tumor cells that survive therapy have a high probability of forming secondary tumors. In particular, recent studies showed that gliomas contain cancer stem cells that are resistant to therapy [5] [6] [7] . Therefore, these stem cells are assumed to be one of the main causes of gliomas recurrence [8, 9] , and selective removal of cancer stem cells is crucial for gliomas therapy.
Drug delivery systems (DDS) and photodynamic therapy (PDT) have greatly advanced the selective removal of tumor cells with high specificity and low adverse effects [10] [11] [12] [13] [14] . 5-aminolevulinic acid (5-ALA) was used to image the area of malignant gliomas during a surgery [15] . Malignant gliomas have been treated with various photosensitizers such as Photofrin®, Laserphyrin®, and Foscan®. These phototoxic dyes were specifically delivered to malignant tumors via an enhanced permeation and retention effect. To enhance the specificity of these treatments for cancer cells, medicines and dyes are often labeled with a cancer antibody. One such phototoxic dye, IR700, is activated by infrared light that transmits well in tissues [16, 17] . Recently, clinical trials investigating the photoimmunotherapy effect of IR700 labeled with the antibody have been initiated in the USA. To maximize the specificity and removal of cancer cells by IR700, it is very important to quantitatively evaluate the processes of cell damage and cell death. However, the details of these processes have not been clearly defined.
In this study, we quantitatively evaluated the photoimmunotherapy effects of IR700 on tumor cell damage. IR700 was conjugated to an anti-CD133 antibody, which specifically targets malignant gliomas and stem cells is endocytosed into the cells. The process of cell damage was evaluated by image analysis obtained by phase-contrast and fluorescence microscopy. This study developed a new and easy method for the quantitative evaluation of cell activity and damage through the measurement of intensity fluctuation in phase-contrast images.
Specifically, acidic vesicles containing IR700 were damaged by the activation of IR700, causing permeabilization of the vesicle membrane, which resulted in cell death.
Experimental section

2-1. Materials
Near-infrared fluorescent dye, IRDye 700DX NHS ester (IR700), was purchased from LI-COR Bioscience. LysoTracker Yellow HCK-123, pHrodo Green AM (Intracellular pH Indicator), and anti-rabbit IgG (H+L) labeled with AlexaFluor 568 were purchased from ThermoFisher Science. PKH26 Linker Kit was purchased from Sigma-Aldrich Co. LLC. Rabbit anti-CD133 antibody and goat anti-Rabbit IgG (H+L) were purchased from Biorbyte and ThermoFisher Science, respectively. The Annexin-V-Cy5 Apoptosis Detection Kit was purchased from BioVision, Inc. Ethidium homodimer-1 (EthD-1), paraformaldehyde, sodium dihydrogen phosphate dihydrate and sodium dihydrogen phosphate were purchased from Wako Pure Chemicals. Glioma stem cells (BT142 class 3) and gliomas (U87MG, class 4) were purchased from the American Type Culture Collection (ATCC). NeuroCult NS-A basal medium and proliferation supplement were purchased from VERITAS, and platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and fibroblast growth factor (FGF) were from PeproTech Inc. Dulbecco's modified Eagle's medium (DMEM) was purchased from Sigma, and Dulbecco's modified phosphate-buffered saline (PBS) was purchased from Takara Bio Inc. Fetal bovine serum (FBS) was purchased from GIBCO, penicillin-streptomycin was purchased from Wako Pure Chemicals, and the TrypLE express enzyme was purchased from ThermoFisher Science.
Glass-bottom dishes were purchased from Matsunami Glass Ind., Ltd.
2-2. Conjugation of IR700 with anti-CD133 antibody
IR700 and the anti-CD133 antibody were conjugated using the protocol described by Mitsunaga et al [16] . IR700 (11.3 g or 5.8 nmol resolved in DMSO to a concentration of 2.5 mol/L) and goat anti-rabbit IgG (121.8 g or 0.8 nmol resolved in PBS to a concentration of 13.3 mol/L) were reacted in a solution containing 10 mM Na 2 HPO 4 (pH: 8.0) for 2 hours at room temperature. Then, the IR700 and anti-rabbit IgG complex was mixed with the rabbit anti-CD133 antibody to prepare the conjugate of IR700, anti-rabbit IgG and anti-CD133 (IR700-CD133).
IR700-CD133 specifically bound to gliomas (BT142 and U87MG) expressing CD133 on the cell membrane [18] , while the conjugate did not bind to neuron-like Cath.a-differenciated cells (Supporting Figures 1(a) and (c) ). indicate that CD133-IR700 conjugate bound specifically to the CD133-expressing cells.
2-3. Preparation of gliomas
BT142 cells were cultured and formed neurospheres in medium-BT (NS-A basal medium supplemented with 10% V/V proliferation supplement, 20 ng/mL EGF, 20 ng/mL FGF, 100 ng/mL PDGF, 2 g/mL heparan sulfate and 100 U/mL penicillin). The cells were triturated with a micropipette to produce a single-cell suspension. The single cells were seeded onto glass-bottom dishes at a concentration of 1.0 × 10 4 cells/mL. Adherent U87MG cells were cultured in medium-U (DMEM supplemented with 10% FBS, 100 U/mL penicillin). After establishing confluent culture at 37°C with 5% CO 2 and 95% air, the cells were recovered by treatment with the TrypLE express enzyme (1×). Recovered cells were seeded at a concentration of 1.0 × 10 4 cells on a glass-bottom dish coated with 2% collagen, and cells were incubated for one day in medium-BT after initial adhesion.
2-4. Preparation of gliomas
U87MG and BT142 cells from the glass-bottom dishes were loaded with 10 and 40 nM of IR700-CD133 in medium-BT and incubated for 1 hour at 37°C with 5% CO 2 and 95% air. After washing with medium, the dishes were placed on a microscope stage with a controlled temperature and CO 2 concentration. Figure 1 (a)).
2-5. Fluorescence microscopy of gliomas
Results
Tumor cell damage and death induced by IR700 phototoxicity
We investigated the changes in cell shape induced by IR700 phototoxicity activated by the red laser. IR700 was first reacted with goat anti-rabbit IgG as the secondary antibody, as used in immunocytochemistry. Then, the IR700-anti-rabbit complex was bound to the rabbit anti-CD133 antibody as the primary antibody (IR700-CD133). Using this method, the primary antibody could bind the target cell without changing the IR700-anti-rabbit complex. U87MG and Table 1 ). The ratio increased from 78 to 89% in U87MG and from 22 to 56% in BT142 at 10 and 20 m, respectively, after the photoactivation, indicating that both cells are EthD-1 positive.
We observed the morphology of nucleus stained by EthD-1 and cell shape at 2 hours after photoactivation of IR700 to confirm the modes of cell death. The 
Colocalization of acidic organelles and vesicles containing IR700
IR700-CD133 was endocytosed into tumor cells and was located near the nucleus (Figures 2(b) and (e)). In general endocytosis, materials outside of the cell are taken into the endosomes, which mature to lysosomes during transport to the nucleus [20] . Thus, endosomes containing IR700-CD133 should mature into lysosomes within approximately 1 hour after IR700-CD133 is loaded into the cells.
We investigated the localization of lysosomes and vesicles containing IR700 by LyosTracker staining, as the fluorescence intensity increases in acidic lysosomes.
IR700 was endocytosed into vesicles and transported to a region near the nucleus (Figures 6(a) and (d) ). LysoTracker was detected near the nucleus, as well as in the cell periphery (Figures 6(b) and (e)). IR700 fluorescence (shown by the red color in Figure 6 ) near the nucleus overlapped with the green fluorescence of LysoTracker (Figures 6(c) and (f) ). This finding suggests that most of the vesicles containing IR700 were colocalized with lysosomes. 
pH changes in damaged cells
To evaluate the process of cell damage, the acidic organelles were stained with a These results indicate that with the exception of the early stage in U87MG cells, photodamage increased the pH of cells and that this effect was presumably induced by a defect of the lysosomes.
Discussion
The selective removal of tumor cells has long been anticipated in the medical field. Indeed, IR700 bound to antibodies has been developed for the selective removal of tumor cells by photodamage [16, 17] . Here, we determined the type of cell death induced by IR700 phototoxicity and then measured the changes in 
Conclusion
The processes of glioma (U87MG) and glioma stem cell (BT142) damage were 
